These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Fluorinated-NHC Transition Metal Complexes: Leading Characters as Potential Anticancer Metallodrugs. Rufino-Felipe E; Colorado-Peralta R; Reyes-Márquez V; Valdés H; Morales-Morales D Anticancer Agents Med Chem; 2021; 21(8):938-948. PubMed ID: 32900353 [TBL] [Abstract][Full Text] [Related]
8. A simple synthetic entryway into new families of NHC-gold-amido complexes and their Martynova EA; Scattolin T; Cavarzerani E; Peng M; Van Hecke K; Rizzolio F; Nolan SP Dalton Trans; 2022 Mar; 51(9):3462-3471. PubMed ID: 35142328 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes. Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642 [TBL] [Abstract][Full Text] [Related]
11. Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell Lines. Curado N; Giménez N; Miachin K; Aliaga-Lavrijsen M; Cornejo MA; Jarzecki AA; Contel M ChemMedChem; 2019 Jun; 14(11):1086-1095. PubMed ID: 30924298 [TBL] [Abstract][Full Text] [Related]
12. Acetylated galactopyranosyl N-heterocyclic monocarbene complexes of Silver(I) as novel anti-proliferative agents in a rhabdomyosarcoma cell line. Hobsteter AW; Irazoqui AP; Gonzalez A; Picco AS; Rubert AA; Buitrago CG; Lo Fiego MJ; Silbestri GF Bioorg Med Chem; 2024 Jun; 107():117756. PubMed ID: 38759255 [TBL] [Abstract][Full Text] [Related]
13. N-heterocyclic carbenes (NHC) with 1,2,4-oxadiazole-substituents related to natural products: synthesis, structure and potential antitumor activity of some corresponding gold(I) and silver(I) complexes. Maftei CV; Fodor E; Jones PG; Freytag M; Franz MH; Kelter G; Fiebig HH; Tamm M; Neda I Eur J Med Chem; 2015 Aug; 101():431-41. PubMed ID: 26185007 [TBL] [Abstract][Full Text] [Related]
14. Silver(I) complexes of mono- and bidentate N-heterocyclic carbene ligands: synthesis, crystal structures, and in vitro antibacterial and anticancer studies. Haque RA; Choo SY; Budagumpi S; Iqbal MA; Al-Ashraf Abdullah A Eur J Med Chem; 2015 Jan; 90():82-92. PubMed ID: 25461313 [TBL] [Abstract][Full Text] [Related]
15. Metal-N-heterocyclic carbene complexes as anti-tumor agents. Hu C; Li X; Wang W; Zhang R; Deng L Curr Med Chem; 2014 Apr; 21(10):1220-30. PubMed ID: 24350852 [TBL] [Abstract][Full Text] [Related]
17. Cyclometalated Gold(III) Complexes Containing N-Heterocyclic Carbene Ligands Engage Multiple Anti-Cancer Molecular Targets. Fung SK; Zou T; Cao B; Lee PY; Fung YM; Hu D; Lok CN; Che CM Angew Chem Int Ed Engl; 2017 Mar; 56(14):3892-3896. PubMed ID: 28247451 [TBL] [Abstract][Full Text] [Related]
18. A Patil S; P Hoagland A; A Patil S; Bugarin A Future Med Chem; 2020 Dec; 12(24):2239-2275. PubMed ID: 33228391 [No Abstract] [Full Text] [Related]
19. A promising future of metal-N-heterocyclic carbene complexes in medicinal chemistry: The emerging bioorganometallic antitumor agents. Zhao Q; Han B; Peng C; Zhang N; Huang W; He G; Li JL Med Res Rev; 2024 Sep; 44(5):2194-2235. PubMed ID: 38591229 [TBL] [Abstract][Full Text] [Related]
20. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs. Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]